Buy BELLAST® SOFT L Online

Product Description

BELLAST® SOFT L Product Overview

BELLAST® SOFT L is a hyaluronic acid (HA) dermal filler tailored for treating fine wrinkles and delicate facial lines, including crow’s feet and perioral wrinkles. Formulated with cross-linked hyaluronic acid and 3 mg of lidocaine to minimize discomfort, BELLAST® SOFT L is intended for areas requiring subtle volume and precision. Leveraging High Concentration Cross-Linking (HCXL) Technology, this filler achieves ideal viscosity and stability for sensitive skin areas, allowing for a natural, smooth appearance.

Key Features:

• Hyaluronic Acid Concentration: 18 mg of cross-linked HA
• Lidocaine Content: 3 mg of lidocaine for comfort
• Technology: HCXL cross-linking for enhanced stability and biocompatibility
• Packaging: 1.0 ml syringe, sterile, single-use

BELLAST® SOFT L Indications for Use

BELLAST® SOFT L is designed for fine line correction and subtle volume enhancement. Its soft consistency and lower HA concentration make it ideal for areas with delicate skin, providing natural-looking results in the superficial to mid-dermis.

Primary Indications:

• Crow’s Feet: Smooths fine lines around the eyes.
• Perioral Lines: Reduces fine lines around the mouth.
• Superficial Wrinkles: Treats subtle facial lines and improves hydration.
• Lip Line Definition: Enhances lip contour without adding excessive volume.

BELLAST® SOFT L Dosage Information

Administered using careful injection techniques, BELLAST® SOFT L is designed to achieve fine line smoothing without overcorrection.

Treatment Protocols:

• Injection Volume: 1 ml per session, adjustable based on the area and patient needs.
• Injection Depth: Superficial to mid-dermis for subtle volume restoration.
• Frequency of Treatment: Generally requires one session, with touch-ups every 6-9 months depending on individual preferences and needs.

BELLAST® SOFT L Side Effects and Precautions

BELLAST® SOFT L is well-tolerated, with mild, temporary side effects due to its gentle formulation. The inclusion of lidocaine minimizes injection discomfort.

Common Side Effects:

• Redness and Swelling: Temporary at the injection site, resolving within 1-2 days.
• Bruising: Minor bruising may occur, particularly in sensitive areas.
• Tenderness: Mild tenderness is common but subsides shortly after treatment.

Precautions:

• Aseptic Technique: Essential to prevent infections.
• Contraindications: Avoid in patients with autoimmune diseases, allergies to HA or lidocaine, or active infections.
• Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding.
• Post-Treatment Care: Patients should avoid strenuous physical activity and sun exposure for at least 24 hours following treatment.

BELLAST® SOFT L Clinical Studies or Real-World Outcomes

BELLAST® SOFT L has shown significant results in fine line reduction and superficial wrinkle smoothing with high patient satisfaction due to its natural appearance and effective wrinkle reduction.

Key Findings:

• Fine Line Reduction: Patients observed 30-40% improvement in fine line depth post-treatment.
• Natural Volume Restoration: Creates smoother skin without a heavy or artificial appearance.
• Patient Satisfaction: High satisfaction rates due to comfortable injection and effective fine line reduction, with 92% satisfaction at follow-up visits.

Clinical Observations:

• Durability: Effects typically last between 6 to 9 months, particularly around the eyes and mouth.
• Minimal Adverse Effects: The HCXL technology enhances safety and stability, making BELLAST® SOFT L suitable for sensitive areas without significant adverse effects.

BELLAST® SOFT L Composition and Active Ingredients

BELLAST® SOFT L is composed of 18 mg/ml cross-linked hyaluronic acid and 3 mg lidocaine hydrochloride for painless and effective treatment.

Key Ingredients:

• Cross-Linked Hyaluronic Acid (18 mg/ml): Supports skin hydration, smooths fine lines, and improves elasticity.
• Lidocaine (3 mg): Provides pain relief, enhancing comfort during and after treatment.
• HCXL Technology: Creates a stable, biocompatible HA gel, minimizing potential migration and ensuring natural results.

BELLAST® SOFT L Drug Interactions

BELLAST® SOFT L is a localized filler with minimal systemic effects, which lowers the risk of drug interactions.

Important Considerations:

• Combination with Other Treatments: Can be combined with other fillers or biostimulation treatments, though a two-week interval is advised between procedures.
• Anticoagulants: Patients on blood thinners should be informed of the increased likelihood of bruising.
• Immunosuppressive Therapy: Use cautiously with immunosuppressive treatments, as patients may be more prone to infection.